Hematology - Oncology Therapy

Hematology - Oncology Therapy

by Michael Boyiadzis, James Frame, David R. Kohler, Tito Fojo
     
 

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care—Updated with the Latest Treatment Regimens

More than 500 treatment regimens

Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design

Overview

The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care—Updated with the Latest Treatment Regimens

More than 500 treatment regimens

Hematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology.

Hematology-Oncology Therapy is divided into three sections:

Oncology:

Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens, drugs, and biological agents

Supportive Care, Drug Preparation, Complications, and Screening:

Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much more

Selected Hematologic Diseases:

Delivers an authoritative guide to therapy for the principal diseases in consultative hematology

This edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.

Editorial Reviews

The Annals of Pharmacotherapy
"The authors have accomplished their goal of producing a readily available hematology and oncology reference for office-and hospital-based clinicians. Clinicians of all disciplines involved in the treatment of patients with hematology and oncology disorders would benefit from the addition of Hematology-Oncology Therapy to their library. It would also be beneficial to pharmacies specializing in chemotherapy preparation in both community clinics and hospitals. Students and postgraduate residents and fellows would also benefit from this reference book."--The Annals of Pharmacotherapy

Doody's Review Service
Reviewer: Tanya Siddiqi, M.D.(City of Hope)
Description: This comprehensive resource for clinicians taking care of hematology/oncology patients is broken down conveniently into three sections that present the material in a concise manner using a number of tables to convey data. This is a much needed update of the 2007 edition as there are a number of new therapies.
Purpose: The purpose is to provide an updated, practical resource for practicing hematologists/oncologists. This edition describes almost all the latest therapies, with very few omissions of those just receiving FDA approval this year or still in clinical trials.
Audience: The book is intended for practicing hematologists/oncologists as well as clinical fellows, nurse practitioners, and physician assistants in hematology/oncology. It meets the needs of this audience, and the authors are respected leaders in their respective fields.
Features: The three sections cover oncology; supportive care, drug preparation, complications, and screening; and selected hematologic diseases. The first section concisely covers all aspects of specific cancers, including epidemiology, pathology, workup, staging, survival data, expert opinions, and treatment regimens. Section II covers common scenarios in hematology/oncology practice, such as chemotherapy-induced emesis, pain management, transfusions, and complications, among others. Section III is a guide to common hematological conditions, both benign and malignant. The book uses numerous tables to display data and has easy-to-review text with appropriate subheadings. This format makes this book a comprehensive yet user-friendly reference.
Assessment: This is a well-written, well-structured book that meets its objectives of providing an up-to-date, comprehensive, easily accessible guide for hematologists/oncologists. Important new therapies have been added to this edition, as well as expert opinions for each disease type. Overall, this is an excellent and useful reference. Access to an online version would be of additional benefit to clinicians.

Product Details

ISBN-13:
9780071637893
Publisher:
McGraw-Hill Professional Publishing
Publication date:
06/27/2014
Pages:
1888
Sales rank:
398,634
Product dimensions:
8.80(w) x 11.10(h) x 2.40(d)

Meet the Author

Michael M. Boyiadzis, MD, MHSc, Assistant Professor of Medicine, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, Pittsburgh, PA

James N. Frame, MD, FACP, Clinical Associate Professor, Robert C. Byrd Health Sciences Center of West Virginia, University School of Medicine Charleston Division, Medical Director, David Lee Outpatient Cancer Center, Charleston Area Medical Center Health Systems, Inc., Charleston, WV

David R. Kohler, PharmD, Oncology Clinical Pharmacy Specialist, Bethesda, Maryland

Tito Fojo, MD, PhD, Senior Investigator, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MA

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >